openPR Logo
Press release

FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety

03-30-2012 04:04 AM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants.

Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems.

The two-day panel, which is expected to include input from scientists, metal hip recipients and doctors, will meet in June to discuss failure rates, metal ion testing, patient risks factors, revision surgeries and health complications associated with these devices. FDA officials will use this information to determine whether new testing standards and review requirements should be imposed before medical devices are allowed to reach the market. Dr. William Maisel, deputy director of science at FDA's Center for Devices and Radiological Health, issued a statement which read, "We are asking outside scientific and medical experts to discuss recent information on these devices so that the agency can continue to make reliable safety recommendations."

Concern over the safety of metal hip implants has continued to mount since Johnson & Johnson and DePuy Orthopedics announced a recall of their ASR hip implants in August 2010. The recall was issued after data from joint registries in the U.K. and Australia indicated that the all-metal hips were failing at a rate of 12 to 13 percent. Patients who received a DePuy ASR hip have reported numerous complications, including pain, swelling, joint damage and loss of mobility and many patients have required additional revision surgery to correct the problems.

In addition to these complications, concerns have been raised over possible metal poisoning caused by the artificial hips. Health officials in the U.K. have issued updated health guidelines for patients who received a metal hip implant. The recommendations include lifetime testing for the presence of increased metal ions in the blood and regular MRI scans to detect complications. Earlier this month, a group of British researchers published a study in The Lancet medical journal calling for a full-scale ban on metal hip implants.

Attorney Jeffrey Nadrich believes that the number of DePuy hip lawsuits will continue to mount as more patients are made aware of the recall. Patients who experience complications caused by a metal hip implant may be eligible to file a claim for compensation. These individuals are encouraged to seek the aid of an experienced personal injury lawyer to discuss their legal rights.

Nadrich & Cohen LLP is offering confidential, no-cost consultations to patients who believe they were injured by a DePuy metal hip. Help is available by calling the firm’s injury hotline at 1-800-718-4658 or by completing an online contact form at www.depuyhipreplacementlawyers.net.

Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California specializing in handling mass tort actions and representing individuals in cases involving pharmaceutical companies and medical device manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.

In addition to handling DePuy hip injury claims, the firm is also investigating cases involving Yaz, Actos, Zoloft, Fosamax, Paxil, Wright Conserve Hips, Stevens-Johnson Syndrome, Benzene, Reflex Sympathy Dystrophy, Fen Phen and Asbestos exposure. All cases are handled on a contingency basis.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety here

News-ID: 216329 • Views: 4276

More Releases from Nadrich & Cohen LLP

Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the
Bayer Agrees to Settlement in 70 Yaz Side Effects Lawsuits
Nadrich & Cohen, LLP reports that Bayer has agreed to settlements with a number of plaintiffs who sued the company over Yaz side effects. Los Angeles, CA, March 5, 2012 – National law firm Nadrich & Cohen, LLP reports that Bayer Healthcare has agreed to settle approximately 70 lawsuits filed on behalf of women who claim they were seriously injured by Yaz birth control pills. The amount of the settlements has

All 5 Releases


More Releases for DePuy

Global Bone Fixation Plate Market 2018 - DePuy Synthes, Stryker, BBraun
Apex Market Reports, recently published a detailed market research study focused on the “Bone Fixation Plate Market” across the global, regional and country level. The report provides 360° analysis of “Bone Fixation Plate Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bone
Global Spine Surgery Market 2018 - Medtronic, DePuy Synthes, NuVasive, Stryker
Apex Market Reports, recently published a detailed market research study focused on the “Spine Surgery Market” across the global, regional and country level. The report provides 360° analysis of “Spine Surgery Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Spine Surgery on
Spinal Intervention Market 2017- Abbott, Medtronic, DePuy Synthes, BioControl Me …
Apex Market Reports, recently published a detailed market research study focused on the "Spinal Intervention Market" across the global, regional and country level. The report provides 360° analysis of "Spinal Intervention Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Spinal Intervention industry, and estimates the future trend of Spinal Intervention market
Extremity Reconstruction Market Share 2017-2022 DePuy Synthes, Stryker Corporati …
Global Extremity Reconstruction Market Research Report 2012-2022 A recent report discusses the market study on "Extremity Reconstruction Market" over the global and major regions, from angles of manufacturers, product types and end industries. This “Extremity Reconstruction Market” research study involved the extensive usage of both primary and secondary data sources, The report on the global Extremity Reconstruction market uses the top-down and bottom-up approaches to define, analyze, and describe the
Global Cranial Implant Market 2017 : Biomet, Stryker, DePuy Synthes & Aesculap
The Market Research Store report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Cranial Implant market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people who are in need
Global Tibial Bearings Market 2017 - Zimmer, DePuy Synthes, Biomet, Stryker
The Tibial Bearings Market 2017 examines the performance of the Tibial Bearings market, enclosing an in-depth judgment of the Tibial Bearings market state and the competitive landscape globally. This report analyzes the potential of Tibial Bearings market in the present as well as the future prospects from various angles in detail. The Global Tibial Bearings Market 2017 report includes Tibial Bearings industry volume, market Share, market Trends, Tibial Bearings Growth aspects,